	US 12,257,260 B2
	Pharmaceutical use of anemoside B4 against acute gouty arthritis
Qi Liu, Beijing (CN)
Appl. No. 17/286,803
Filed by Qi Liu, Beijing (CN)
PCT Filed Dec. 21, 2018, PCT No. PCT/CN2018/122655 § 371(c)(1), (2) Date Apr. 19, 2021, PCT Pub. No. WO2020/077819, PCT Pub. Date Apr. 23, 2020.
Claims priority of application No. 201811214694.3 (CN), filed on Oct. 18, 2018.
Prior Publication US 2021/0338700 A1, Nov. 4, 2021
Int. Cl. A61K 31/704 (2006.01); A61K 9/00 (2006.01); A61P 19/02 (2006.01)

CPC A61K 31/704 (2013.01) [A61K 9/0019 (2013.01); A61P 19/02 (2018.01)]

10 Claims

1. A method for treatment of acute gouty arthritis, comprising administering a drug to a patient in need thereof, wherein the drug comprises anemoside B4, colchicine, one or more active ingredients selected from non-steroidal anti-inflammatory drugs and glucocorticoids, and a pharmaceutically acceptable excipient.